Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Schrödinger logo — Transforming drug discovery and materials research

Schrödinger

Transforming drug discovery and materials research

Founded 1990 United States New York, United States 1002 employees IPO Total: $871.40M Biotechnology, Enterprise Software +1

General Information

Company Name Schrödinger
Founded Year 1990
Location United States New York, United States +8
Employees 1002
Industries Biotechnology, Enterprise Software, Pharmaceutical
Funding Stage IPO
Social

Get notified when Schrödinger moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Aug 12, 2026

Schrödinger is attending the 2026 Medicinal Chemistry GRC, with Aleksey Gerasyuto presenting on "In Silico Driven Discovery of SGR-3515" on August 12, 2026.

Growth Metrics Aug 11, 2026

A month after launch, Schrödinger's Bunsen AI co-scientist now handles 80% of job submissions on the company's multi-thousand-GPU internal supercomputer.

Get alerts when Schrödinger shows new signals

AI Insight

Bounce Watch AI
2 weeks ago

Schrödinger is strategically enhancing its computational platform by launching Bunsen, a new AI platform, further deepening its technology collaborations with industry giants NVIDIA and Google Cloud. This aggressive move into advanced AI for drug discovery and materials research has quickly garnered industry recognition, evidenced by its finalist nomination for the 2026 Fierce AI Innovation Awards. The company is clearly positioning itself at the forefront of AI-driven scientific discovery, reinforcing its core offerings.

Signal Types
Product Launch Partnership Award
Strategic Labels
AI Platform Development Strategic Partnerships Innovation Leadership
Next Move: Product Development
·
Impact: 9/10
·
Ideal For: AI/Biotech Growth Funds — Public Equity

About Schrödinger

Schrödinger is a pioneering entity in the intersection of biotechnology, enterprise software, and pharmaceutical industries, dedicated to "Transforming drug discovery and materials research". Established in 1990, the company operates from its headquarters in the United States, serving a global clientele across more than 70 countries.

At the heart of Schrödinger's innovation is its industry-leading computational platform, which enhances research in biopharmaceutical and industrial sectors, as well as academic and government labs. Beyond its platform, Schrödinger engages in collaborative and wholly-owned drug discovery programs spanning various therapeutic domains.

Recently, the company secured a $10.00M grant investment from the Bill & Melinda Gates Foundation on July 1, 2024. This funding underscores the company's commitment to scientific advancement and talent investment, driving forward their mission in drug discovery.

Taxonomy: Computational Platform, Drug Discovery, Materials Research, Biopharmaceutical, Industrial Companies, Academic Institutions, Government Laboratories, Therapeutic Areas, Science Investment, Talent Development, Collaborative Programs, Recruitment Scam Awareness

Services & Products

Computational Platform for Drug and Materials Discovery
Life Science and Materials Science Solutions
Proprietary and Collaborative Drug Discovery Programs
Online Educational Resources

Target Customers

Academics Biotech & Pharmaceutical Companies Research IT Teams Materials Engineering Teams Consumer Packaged Goods Manufacturers

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Jul 2024
Grant •••••• 1
Investor
01 Nov 2021
Post Ipo Equity •••••• - 01 Aug 2020
IPO •••••• - 01 Feb 2020
Series F •••••• 4
Investor Investor Investor
•••• •••• 		01 May 2019

View All 10 Funding Rounds

Schrödinger Alternatives & Competitors

View All Alternatives
Schrödinger vs
JobTarget
JobTarget United States

Empowering Recruitment Through Data

348 employees
Internet, Human Resources
Compare Schrödinger vs JobTarget
Schrödinger vs
Thompsons Limited
Thompsons Limited Canada

Thompsons is now The Andersons. View updates at https://www.linkedin.com/company/the-andersons-inc

64 employees
Agriculture, Marketing
Schrödinger vs
AsclepiX Therapeutics
AsclepiX Therapeutics United States

Fraud Alert Regarding Third Party Employment Agencies

Series A
8 employees
Biotechnology, Health Care
Compare Schrödinger vs AsclepiX Therapeutics
Also compare with: Schrödinger vs AllRetailJobs.com AllRetailJobs.com View all alternatives

FAQ About Schrödinger

Transforming drug discovery and materials research
Schrödinger was founded in 1990.
Schrödinger is headquartered in New York, United States.
Schrödinger operates in the following industries: Biotechnology, Enterprise Software, Pharmaceutical.
Schrödinger has approximately 1002 employees.
Schrödinger has completed 10 funding rounds, raising a total of $871.40M. The latest funding stage is IPO.
Schrödinger offers: Computational Platform for Drug and Materials Discovery, Life Science and Materials Science Solutions, Proprietary and Collaborative Drug Discovery Programs, Online Educational Resources.
Top alternatives and competitors to Schrödinger include JobTarget, Thompsons Limited, AsclepiX Therapeutics, AllRetailJobs.com, Core Business Technology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Schrödinger and JobTarget are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Schrödinger and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy